New leadership puts patients second - Recensione dipendente - Sales presso Octave Bioscience

2,0
5 mar 2025
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Novel blood test that helps neurologists objectively manage patients with MS.

Svantaggi

New leadership puts their goal of receiving next level funding/revenue over patient care. Drove cost of the test up by 500% for MS patients that already had difficulty affording the test. Tarnished relationships with providers and their staff.

Esplora altre recensioni su Octave Bioscience

5,0
3 dic 2024
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Great team at this fine company

Svantaggi

I did not have any downsides

4,0
1 lug 2025
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Good science Good coworker Remote

Svantaggi

Uncertainties of startups such as funding and job securities

Vedi recensioni per: Utile|Valutazione|Data|Tutto